Volume 55, Issue 2, Pages (February 1999)

Slides:



Advertisements
Similar presentations
Renal registry in Hong Kong—the first 20 years Chi Bon Leung, Wai Lun Cheung, Philip Kam Tao Li Kidney International Supplements Volume 5, Issue 1, Pages.
Advertisements

Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Volume 66, Issue 6, Pages (December 2004)
Buffer transport in peritoneal dialysis
Volume 70, Pages S138-S145 (November 2006)
Volume 70, Issue 8, Pages (October 2006)
Propofol-related green urine
End-stage renal disease in developing countries
Use of icodextrin in high transport ultrafiltration failure
Chronic renal failure from lead: myth or evidence-based fact?
Volume 53, Issue 4, Pages (April 1998)
Continuous renal replacement therapy in the critically ill patient
The risk of hospitalization and modality failure with home dialysis
Section 5: Dialysis Interventions for Treatment of AKI
Volume 57, Issue 6, Pages (June 2000)
Volume 59, Issue 1, Pages (January 2001)
Volume 26, Issue 2, Pages (February 2018)
Volume 63, Issue 2, Pages (February 2003)
Volume 77, Issue 1, Pages 5-6 (January 2010)
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 70, Issue 11, Pages (December 2006)
Volume 87, Issue 2, Pages (February 2015)
Volume 73, Pages S5-S17 (April 2008)
Pharmacokinetics of icodextrin in peritoneal dialysis patients
Volume 73, Pages S94-S101 (April 2008)
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure  A. Parikova, W. Smit, D.G. Struijk,
Volume 58, Issue 2, Pages (August 2000)
Volume 76, Issue 6, Pages (September 2009)
Disaster nephrology: crush injury and beyond
The third World Kidney Day: Looking back and thinking forward
Clifford J. Holmes, Dirk Faict  Kidney International 
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Microbiology and outcomes of peritonitis in North America
Nephrology Crossword: Peritoneal Dialysis
Calcium sensing in podocytes
Volume 66, Issue 1, Pages (July 2004)
Future of icodextrin as an osmotic agent in peritoneal dialysis
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
Profiling of peritoneal ultrafiltration
Volume 71, Issue 4, Pages (February 2007)
Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6?  Peter Stenvinkel, Peter Barany, Olof Heimbürger, Roberto Pecoits-Filho,
Circadian regulation of renal function
Volume 60, Issue 2, Pages (August 2001)
Volume 65, Issue 1, Pages (January 2004)
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Peritoneal dialysis in Mexico
The course of the remnant kidney model in mice
Organ transplantation goes to the movies
Volume 56, Pages S41-S45 (November 1999)
Is it the low-protein diet or simply the salt restriction?
Quantification of free water transport in peritoneal dialysis
Volume 70, Issue 3, Pages (August 2006)
Review of clinical trial experience with icodextrin
Importance of blood pressure control in hemodialysis patient survival
Volume 70, Issue 5, Pages (September 2006)
Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller 
Volume 61, Issue 2, Pages (February 2002)
Volume 65, Issue 1, Pages (January 2004)
Hisataka Kobayashi, Peter L. Choyke  Kidney International 
Strategies for iron supplementation: Oral versus intravenous
The International Pediatric Peritonitis Registry: Starting to walk
Volume 59, Issue 1, Pages (January 2001)
Attitudes and predictive factors for live kidney donation: A comparison of live kidney donors versus nondonors  Lynn Stothers, William A. Gourlay, Li.
Development and differentiation of endothelium
Gentamicin plasma and peritoneal dialysate concentrations in peritoneal dialysis patients with peritonitis. Gentamicin plasma and peritoneal dialysate.
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Metabolic and laboratory effects of icodextrin
Presentation transcript:

Volume 55, Issue 2, Pages 667-673 (February 1999) Hyaluronan decreases peritoneal fluid absorption: Effect of molecular weight and concentration of hyaluronan  Tao Wang, Hui-Hong Cheng, Olof Heimbürger, Chi Chen, Jacek Waniewski, Jonas Bergström, Bengt Lindholm  Kidney International  Volume 55, Issue 2, Pages 667-673 (February 1999) DOI: 10.1046/j.1523-1755.1999.00279.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Intraperitoneal volume versus time: Effect of different of molecular weights and concentrations of hyaluronan. Symbols are: (□) control group (N = 6); (◊) HA85K group (N = 6); (○) HA280K group (N = 6); (▪) HA500K group (0.01% HA group; N = 6); (○) HA4M group (N = 6); () 0.05% HA group (N = 6); (○) 0.1% HA group (N = 6); () 0.5% HA group (N = 6). Kidney International 1999 55, 667-673DOI: (10.1046/j.1523-1755.1999.00279.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 The RISA elimination rate from the peritoneal cavity. Abbreviations are: KE, the total RISA elimination rate representing the fluid absorption rate from the peritoneal cavity; KEB, the RISA elimination rate to the blood from the peritoneal cavity representing the peritoneal lymphatic absorption; KET, the RISA elimination rate to the peritoneal tissue. Symbols are: (□) control group; (▨) HA85K group; (▧) HA280K group; (▪) HA500K group (0.01% HA group); (▤) HA4M group; () 0.05% HA group; () 0.1% HA group; () 0.5% HA group. Significant differences are marked. *P < 0.05 compared with the control group; **P < 0.01 compared with the control group (mean±sd). Kidney International 1999 55, 667-673DOI: (10.1046/j.1523-1755.1999.00279.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 3 Transcapillary ultrafiltration rate between 3minutes and 240minutes of the dwell. (a) P < 0.05 compared with the control and HA500K groups. (b) P < 0.05 compared with the control, 0.01% HA, and 0.5% HA groups. (c) P < 0.05 compared with the 0.5% HA group. Symbols are the same as in Figure 2. Kidney International 1999 55, 667-673DOI: (10.1046/j.1523-1755.1999.00279.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 4 Schematic description of the effect of different molecular weights and different concentrations of hyaluronan (in the peritoneal membrane or within the filter “cake”) on the peritoneal fluid absorption. Abbreviations are: Ci, the concentration of hyaluronan; Mi, the molecular weight of hyaluronan. (Modified from Berriaud et al11.) Kidney International 1999 55, 667-673DOI: (10.1046/j.1523-1755.1999.00279.x) Copyright © 1999 International Society of Nephrology Terms and Conditions